Observational studyMedicine2021

Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.

Victoria Birlutiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.